The bill proposes the enactment of section 124.826 of the Revised Code, which establishes a reimbursement program for state employees and elected officials for out-of-pocket costs associated with GLP-1 drugs, a class of medications approved for chronic weight management. The bill defines key terms such as "GLP-1 drug," "pharmacy," and "physician," and outlines the eligibility criteria for reimbursement. Specifically, reimbursements will cover costs for GLP-1 drugs purchased through approved channels, with a maximum reimbursement of $500 per month during the first year and $250 during the second year of eligibility.

Additionally, the bill stipulates that employees or officials can apply for reimbursements for a maximum of 24 consecutive months, with specific conditions regarding body mass index and weight management. After this period, they may reapply for another 24-month reimbursement period if they meet certain weight criteria. The director of administrative services is tasked with overseeing the reimbursement process and will adopt rules to implement the program. Overall, the bill aims to support state employees and officials in managing their weight through access to necessary medications.